Editorial: The heart lung disease: a need for novel definitions and understanding of pathological overlaps in the COVID-19 era and beyond.
作者信息
Omar Alaa Mabrouk Salem, Chilimuri Sridhar, Bella Jonathan N
机构信息
Department of Cardiology, Mount Sinai Morningside, New York, NY, United States.
Icahn School of Medicine at Mount Sinai, New York, NY, United States.
出版信息
Front Cardiovasc Med. 2023 Dec 14;10:1329841. doi: 10.3389/fcvm.2023.1329841. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: The heart lung disease: a need for novel definitions and understanding of pathological overlaps in the COVID-19 era and beyond.社论：心肺疾病：在新冠疫情时代及以后，需要对病理重叠有新的定义和理解。
Front Cardiovasc Med. 2023 Dec 14;10:1329841. doi: 10.3389/fcvm.2023.1329841. eCollection 2023.
2
Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.吸烟者 COVID-19 肺炎肺组织中血管紧张素转换酶 2 受体基因表达降低。
Biomolecules. 2021 May 26;11(6):796. doi: 10.3390/biom11060796.
3
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.血管紧张素 II 受体阻滞剂和 ACE（血管紧张素转换酶）抑制剂对 COVID-19 合并高血压患者病毒感染、炎症状态和临床结局的影响：一项单中心回顾性研究。
Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29.
4
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.停止使用 ACEI 和 ARB 类药物对 COVID-19 患者的潜在有害影响。
Elife. 2020 Apr 6;9:e57278. doi: 10.7554/eLife.57278.
5
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2（血管紧张素转换酶 2）：对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
6
Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.大鼠中野百合碱诱导的心肺损伤：血管紧张素转换酶抑制剂CL242817的改善作用
Proc Soc Exp Biol Med. 1986 Sep;182(4):483-93. doi: 10.3181/00379727-182-42370.
7
The Impact of and Gene Polymorphisms in Pulmonary Diseases Including COVID-19.和基因多态性对包括 COVID-19 在内的肺部疾病的影响。
In Vivo. 2022 Jan-Feb;36(1):13-29. doi: 10.21873/invivo.12672.
8
Importance of angiotensin-converting enzyme in pulmonary hypertension.
Cardiology. 1995;86 Suppl 1:9-15. doi: 10.1159/000176939.
9
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.法国因 COVID-19 住院的患者和接触血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的结果：ACE-CoV 研究的结果。
Fundam Clin Pharmacol. 2021 Feb;35(1):194-203. doi: 10.1111/fcp.12613. Epub 2020 Oct 28.
10
Therapy with RAS inhibitors during the COVID-19 pandemic.在 COVID-19 大流行期间使用 RAS 抑制剂进行治疗。
J Cardiovasc Med (Hagerstown). 2021 May 1;22(5):329-334. doi: 10.2459/JCM.0000000000001160.
本文引用的文献
1
Association between right ventricular dysfunction and in-hospital mortality in surges of SARS-CoV-2 infection attributed to the Alpha, Delta, and Omicron variants.由阿尔法、德尔塔和奥密克戎变种导致的SARS-CoV-2感染激增期间右心室功能障碍与院内死亡率之间的关联。
Int J Cardiol Heart Vasc. 2022 Dec;43:101150. doi: 10.1016/j.ijcha.2022.101150. Epub 2022 Nov 17.
2
Combined atrioventricular longitudinal strain rate during isovolumic contraction predicts pulmonary capillary wedge pressure in patients with systolic dysfunction.等容收缩期联合房室纵向应变率可预测收缩功能障碍患者的肺毛细血管楔压。
Am J Cardiovasc Dis. 2021 Aug 15;11(4):530-538. eCollection 2021.
3
Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement.COVID-19 中的心肺相互作用：床旁超声心动图对右心室受累监测的预后影响和作用。
Heart Fail Rev. 2022 Jul;27(4):1325-1339. doi: 10.1007/s10741-021-10108-7. Epub 2021 Apr 17.
4
COVID-19 and renin-angiotensin system modulators: what do we know so far?新型冠状病毒肺炎与肾素-血管紧张素系统调节剂：我们目前了解多少？
Expert Rev Cardiovasc Ther. 2020 Nov;18(11):743-748. doi: 10.1080/14779072.2020.1814143. Epub 2020 Aug 31.
5
Lung function and cardiovascular disease: A link.肺功能与心血管病：关联。
Trends Cardiovasc Med. 2021 Feb;31(2):93-98. doi: 10.1016/j.tcm.2019.12.009. Epub 2020 Jan 3.
6
Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.肺源性心脏病：心肺相互作用及其对患者表型的影响。
Pulm Circ. 2013 Jan;3(1):5-19. doi: 10.4103/2045-8932.109910.
Zotero 插件